Methods for the drug effectiveness review project

Marian McDonagh, Daniel E. Jonas, Gerald Gartlehner, Alison Little, Kim Peterson, Susan Carson, Mark Gibson, Mark Helfand

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comparative effectiveness reviews to inform evidence-based decisions about drugs that would be available to Medicaid recipients. The Project is coordinated by the Center for Evidence-based Policy (CEbP) at Oregon Health & Science University (OHSU), and the systematic reviews are undertaken by the Evidence-based Practice Centers (EPCs) at OHSU and at the University of North Carolina. The reviews adhere to high standards for comparative effectiveness reviews. Because the investigators have direct, regular communication with policy-makers, the reports have direct impact on policy and decision-making, unlike many systematic reviews. The Project was an innovator of methods to involve stakeholders and continues to develop its methods in conducting reviews that are highly relevant to policy-makers. The methods used for selecting topics, developing key questions, searching, determining eligibility of studies, assessing study quality, conducting qualitative and quantitative syntheses, rating the strength of evidence, and summarizing findings are described. In addition, our on-going interactions with the policy-makers that use the reports are described.

Original languageEnglish (US)
Article number140
JournalBMC Medical Research Methodology
Volume12
DOIs
StatePublished - 2012

Fingerprint

Medicaid
Administrative Personnel
Pharmaceutical Preparations
Policy Making
Evidence-Based Practice
Budgets
Decision Making
Communication
Research Personnel
Organizations
Costs and Cost Analysis
Health

ASJC Scopus subject areas

  • Epidemiology
  • Health Informatics

Cite this

Methods for the drug effectiveness review project. / McDonagh, Marian; Jonas, Daniel E.; Gartlehner, Gerald; Little, Alison; Peterson, Kim; Carson, Susan; Gibson, Mark; Helfand, Mark.

In: BMC Medical Research Methodology, Vol. 12, 140, 2012.

Research output: Contribution to journalArticle

McDonagh, M, Jonas, DE, Gartlehner, G, Little, A, Peterson, K, Carson, S, Gibson, M & Helfand, M 2012, 'Methods for the drug effectiveness review project', BMC Medical Research Methodology, vol. 12, 140. https://doi.org/10.1186/1471-2288-12-140
McDonagh, Marian ; Jonas, Daniel E. ; Gartlehner, Gerald ; Little, Alison ; Peterson, Kim ; Carson, Susan ; Gibson, Mark ; Helfand, Mark. / Methods for the drug effectiveness review project. In: BMC Medical Research Methodology. 2012 ; Vol. 12.
@article{6299df6cb3c440dfbe600b69c42fc69a,
title = "Methods for the drug effectiveness review project",
abstract = "The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comparative effectiveness reviews to inform evidence-based decisions about drugs that would be available to Medicaid recipients. The Project is coordinated by the Center for Evidence-based Policy (CEbP) at Oregon Health & Science University (OHSU), and the systematic reviews are undertaken by the Evidence-based Practice Centers (EPCs) at OHSU and at the University of North Carolina. The reviews adhere to high standards for comparative effectiveness reviews. Because the investigators have direct, regular communication with policy-makers, the reports have direct impact on policy and decision-making, unlike many systematic reviews. The Project was an innovator of methods to involve stakeholders and continues to develop its methods in conducting reviews that are highly relevant to policy-makers. The methods used for selecting topics, developing key questions, searching, determining eligibility of studies, assessing study quality, conducting qualitative and quantitative syntheses, rating the strength of evidence, and summarizing findings are described. In addition, our on-going interactions with the policy-makers that use the reports are described.",
author = "Marian McDonagh and Jonas, {Daniel E.} and Gerald Gartlehner and Alison Little and Kim Peterson and Susan Carson and Mark Gibson and Mark Helfand",
year = "2012",
doi = "10.1186/1471-2288-12-140",
language = "English (US)",
volume = "12",
journal = "BMC Medical Research Methodology",
issn = "1471-2288",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Methods for the drug effectiveness review project

AU - McDonagh, Marian

AU - Jonas, Daniel E.

AU - Gartlehner, Gerald

AU - Little, Alison

AU - Peterson, Kim

AU - Carson, Susan

AU - Gibson, Mark

AU - Helfand, Mark

PY - 2012

Y1 - 2012

N2 - The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comparative effectiveness reviews to inform evidence-based decisions about drugs that would be available to Medicaid recipients. The Project is coordinated by the Center for Evidence-based Policy (CEbP) at Oregon Health & Science University (OHSU), and the systematic reviews are undertaken by the Evidence-based Practice Centers (EPCs) at OHSU and at the University of North Carolina. The reviews adhere to high standards for comparative effectiveness reviews. Because the investigators have direct, regular communication with policy-makers, the reports have direct impact on policy and decision-making, unlike many systematic reviews. The Project was an innovator of methods to involve stakeholders and continues to develop its methods in conducting reviews that are highly relevant to policy-makers. The methods used for selecting topics, developing key questions, searching, determining eligibility of studies, assessing study quality, conducting qualitative and quantitative syntheses, rating the strength of evidence, and summarizing findings are described. In addition, our on-going interactions with the policy-makers that use the reports are described.

AB - The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comparative effectiveness reviews to inform evidence-based decisions about drugs that would be available to Medicaid recipients. The Project is coordinated by the Center for Evidence-based Policy (CEbP) at Oregon Health & Science University (OHSU), and the systematic reviews are undertaken by the Evidence-based Practice Centers (EPCs) at OHSU and at the University of North Carolina. The reviews adhere to high standards for comparative effectiveness reviews. Because the investigators have direct, regular communication with policy-makers, the reports have direct impact on policy and decision-making, unlike many systematic reviews. The Project was an innovator of methods to involve stakeholders and continues to develop its methods in conducting reviews that are highly relevant to policy-makers. The methods used for selecting topics, developing key questions, searching, determining eligibility of studies, assessing study quality, conducting qualitative and quantitative syntheses, rating the strength of evidence, and summarizing findings are described. In addition, our on-going interactions with the policy-makers that use the reports are described.

UR - http://www.scopus.com/inward/record.url?scp=84866005491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866005491&partnerID=8YFLogxK

U2 - 10.1186/1471-2288-12-140

DO - 10.1186/1471-2288-12-140

M3 - Article

C2 - 22970848

AN - SCOPUS:84866005491

VL - 12

JO - BMC Medical Research Methodology

JF - BMC Medical Research Methodology

SN - 1471-2288

M1 - 140

ER -